| Topic | Description |
|---|---|
| Target population | Teens 13-17 years of age accross 10 HHS regions in the US |
| Research question | what are the main reasons why teens (aged 13-17) do not receive HPV shots across the 10 HHS region-NIS teen data in 2023? |
| Data source | National immunization survey -Teen( NIS-Teen)(https://www.cdc.gov/nis/media/pdfs/2024/11/NISTEENPUF23HHQUEX.pdf) |
| Problem Statement | Despite the proven effectiveness of the HPV vaccine in explaining the prevalence of cervical cancer, its introduction cannot be targeted nationwide and is in addition to the many cancers that may be associated with HPV. There are issues that may challenge location, ethnicity/race, and economic status. Understanding the barriers to HPV vaccination and pinpointing ways to increase coverage, especially among underserved population, will help reduce the underrepresentation of HPV-related conditions. |
| Impact and Importance | Addressing persistent gaps in HPV vaccination coverage requires targeted interventions to improve provider education, increase vaccine access, and address parental concerns and misinformation. Improving immunization infrastructure, especially in low-income and rural populations, is critical to ensuring equitable coverage of HPV vaccination. Furthermore, evidence-based public health interventions are needed to increase vaccine confidence and uptake. |
| Github repository | https://github.com/nati1515/Vaccine |
| HHS regions | States |
|---|---|
| Region 1 – Boston | Boston, Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont |
| Region 2- Ner York | New Jersey, New York, Puerto Rico, and the Virgin Islands |
| Region 3 – Philadelphia | Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, and West Virginia |
| Region 4- Atlanta | Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee |
| Region 5– Chicago | Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin |
| Region 6- Dallas | Arkansas, Louisiana, New Mexico, Oklahoma, and Texas |
| Region 7 – Kansas City | Iowa, Kansas, Missouri, and Nebraska |
| Region 8- Denver | Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming |
| Region 9 – San Francisco | Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Marshall Islands, and Republic of Palau |
| Region 10- Seattle | Alaska, Idaho, Oregon, and Washington |
My capstone project is using the national immunization survey -Teen( NIS-Teen) which are a critical tool used by the Centers for Disease Control and Prevention (CDC) to monitor vaccination coverage, including the human papillomavirus (HPV) vaccine, tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, and quadrivalent meningococcal conjugate vaccines, among adolescents aged 13–17 years in the United States . The NIS-Teen consists of two main components:
Household Interview Questionnaire: This is conducted with parents or guardians of adolescents to gather information on vaccination status, demographic characteristics, and reasons for vaccine hesitancy or refusal.
Provider-Immunization History Questionnaire: This is sent to healthcare providers to verify the vaccination records of the adolescents listed in the household interviews
Fig: Weighted proportions of HPV vaccination (Vaccinated teen / Total population in the region) in Teens (13-17) across the 10 HHS regions of the US
Fig: Weighted proportions Unvaccination (Unvaccinated teen / Total population in the region) in Teens (13-17) across the 10 HHS regions of the US
Table: Reasons for HPV vaccine hesitancy among US teens (13-18) across 10 HHS region, US
Figure: Percentage of reasons for HPV vaccine hesistancy among US Teens(13-17) stratified by Race
Figure: Number of reasons for HPV vaccine hesistancy among Teens(13-17) across the 10 HHS US Regions stratified by Race
Table: Reasons for HPV vaccine hesitancy among US teens (13-18) stratifed by race and region